Basic Information
IONpath is revolutionizing tissue imaging to accelerate medical discoveries and improve human health. The company’s MIBIscope system leverages Multiplexed Ion Beam Imaging (MIBI) technology, representing a transformative step in tissue imaging by simultaneously multiplexing over 40 markers at single-cell resolution. Leading research institutions as well as biotech and pharmaceutical companies are utilizing the MIBIscope for immunology, immuno-oncology, and neuroscience research requiring high-fidelity multiplex imaging data. In addition to the MIBIscope system, IONpath empowers R&D initiatives of academic, biotech, and pharmaceutical partners through IONpath Research Services.
Ionpath, Inc.
California,United States of America
15~50 people
January 01, 2014
partnerships@ionpath.com

